Items where authors include "Smith, S.A."

Article

Zuntini, A.R. orcid.org/0000-0003-0705-8902, Carruthers, T., Maurin, O. orcid.org/0000-0002-4151-6164 et al. (276 more authors) (2024) Phylogenomics and the rise of the angiosperms. Nature, 629. pp. 843-850. ISSN 0028-0836

Dillon, M.T., Boylan, Z., Smith, D. et al. (10 more authors) (2018) PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours. Clinical and Translational Radiation Oncology, 12. pp. 16-20. ISSN 2405-6308

Smith, S.A., Colley, H.E., Sharma, P. et al. (5 more authors) (2018) Expression and enzyme activity of Cytochrome P450 enzymes CYP3A4 and CYP3A5 in human skin and tissue engineered skin equivalents. Experimental Dermatology, 27 (5). pp. 473-475. ISSN 0906-6705

Smith, S.A., Brown, J.W. orcid.org/0000-0002-3835-8062 and Walker, J.F. (2018) So many genes, so little time: A practical approach to divergence-time estimation in the genomic era. PLoS ONE, 13 (5). e0197433. ISSN 1932-6203

Walladbegi, J., Smith, S.A., Grayson, A. et al. (3 more authors) (2018) Cooling of the oral mucosa to prevent adverse effects of chemotherapeutic agents - an in vitro study. Journal of Oral Pathology and Medicine, 47 (5). pp. 477-483. ISSN 0904-2512

Smith, S.A., Samokhin, A.O., Alfadi, M. et al. (7 more authors) (2017) The IL-1RI co-receptor TILRR (FREM1 isoform 2) controls aberrant inflammatory responses and development of vascular disease. JACC: Basic to Translational Science, 2 (4). pp. 398-414.

Rhodes, D.M., Smith, S.A., Holcombe, M. et al. (1 more author) (2015) Computational modelling of NF-κB activation by IL-1RI and its co-receptor TILRR, predicts a role for Cytoskeletal Sequestration of IκBα in inflammatory signalling. PLoS One, 10 (6). e0129888 . ISSN 1932-6203